Holocene Advisors LP Sells 3,554,232 Shares of CVS Health Corporation $CVS

Holocene Advisors LP lowered its holdings in CVS Health Corporation (NYSE:CVS) by 60.0% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,373,942 shares of the pharmacy operator’s stock after selling 3,554,232 shares during the quarter. Holocene Advisors LP owned about 0.19% of CVS Health worth $163,755,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in CVS. Humankind Investments LLC increased its position in CVS Health by 95.7% in the 2nd quarter. Humankind Investments LLC now owns 22,753 shares of the pharmacy operator’s stock valued at $1,570,000 after acquiring an additional 11,126 shares in the last quarter. IHT Wealth Management LLC lifted its position in shares of CVS Health by 6.5% during the second quarter. IHT Wealth Management LLC now owns 12,299 shares of the pharmacy operator’s stock worth $848,000 after purchasing an additional 753 shares in the last quarter. EHP Funds Inc. acquired a new stake in shares of CVS Health in the second quarter valued at approximately $255,000. Engineers Gate Manager LP increased its holdings in shares of CVS Health by 129.7% in the second quarter. Engineers Gate Manager LP now owns 45,628 shares of the pharmacy operator’s stock valued at $3,147,000 after purchasing an additional 25,767 shares in the last quarter. Finally, Curi Capital LLC bought a new position in CVS Health in the 2nd quarter worth approximately $263,000. 80.66% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on CVS shares. TD Cowen lifted their target price on CVS Health from $100.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday. Jefferies Financial Group lifted their price objective on CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. Barclays upped their target price on shares of CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday. Mizuho lifted their price target on shares of CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a research report on Wednesday. Finally, Robert W. Baird increased their price objective on shares of CVS Health from $82.00 to $92.00 and gave the company an “outperform” rating in a report on Wednesday. Two research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $93.71.

CVS Health Stock Down 1.7%

CVS Health stock opened at $79.45 on Friday. The firm has a market capitalization of $100.85 billion, a price-to-earnings ratio of 209.08, a PEG ratio of 0.80 and a beta of 0.48. The company’s 50 day simple moving average is $78.97 and its 200 day simple moving average is $71.83. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $85.15.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. During the same period last year, the business posted $1.09 earnings per share. The business’s revenue for the quarter was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, sell-side analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s payout ratio is presently 700.00%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.